A study indicates that people are delaying medical care until they are eligible for Medicare, leading to missed cancers, and the Food and Drug Administration approves the first CAR-T cell therapy for multiple myeloma.

by Kate Yandell

Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.

by Bradley Jones

A study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and experts ponder COVID-19 vaccines' role is quelling the evolution of concerning viral variants in people with weakened immune systems.

by Marci A. Landsmann

Lung cancer screening recommendations expand to include more smokers, and a U.K. study finds cancer patients may be less protected from COVID-19 than people without cancer after the first dose of the Pfizer-BioNTech vaccine.

by Kevin McLaughlin

A patient advocate and researcher argue that the U.S. has set insufficiently ambitious cervical cancer screening goals, and Merck withdraws the small cell lung cancer indication for its immunotherapy drug Keytruda.

by Kate Yandell

Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.

by Bradley Jones

Organizations call to prioritize cancer patients for COVID-19 vaccination, researchers analyze rates of “low-value” breast surgeries, and UCLA cancer survivors write letters to patients undergoing treatment.

by Marci A. Landsmann

An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and physicians warn that enlarged lymph nodes after COVID-19 vaccination can be mistaken for signs of breast cancer.

by Kate Yandell

Fecal transplants may improve immunotherapy responses, and more than half of cancer survivors have at least one additional condition that increases their risk of severe COVID-19.

by Kevin McLaughlin

Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and a KRAS inhibitor shows promising phase II trial results.

by Kate Yandell